BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 2180567)

  • 1. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.
    Bigner SH; Friedman HS; Vogelstein B; Oakes WJ; Bigner DD
    Cancer Res; 1990 Apr; 50(8):2347-50. PubMed ID: 2180567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts.
    Bigner SH; Humphrey PA; Wong AJ; Vogelstein B; Mark J; Friedman HS; Bigner DD
    Cancer Res; 1990 Dec; 50(24):8017-22. PubMed ID: 2253244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
    Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
    Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased level of amplification of the c-myc oncogene in tumors induced in nude mice by a human breast carcinoma cell line.
    Modjtahedi N; Lavialle C; Poupon MF; Landin RM; Cassingena R; Monier R; Brison O
    Cancer Res; 1985 Sep; 45(9):4372-9. PubMed ID: 4028021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumorigenicity of SEWA murine cells correlates with degree of c-myc amplification.
    Martinsson T; Ståhl F; Pollwein P; Wenzel A; Levan A; Schwab M; Levan G
    Oncogene; 1988 Oct; 3(4):437-41. PubMed ID: 3078951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-myc overexpression causes anaplasia in medulloblastoma.
    Stearns D; Chaudhry A; Abel TW; Burger PC; Dang CV; Eberhart CG
    Cancer Res; 2006 Jan; 66(2):673-81. PubMed ID: 16423996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene.
    Yanagihara K; Seyama T; Tsumuraya M; Kamada N; Yokoro K
    Cancer Res; 1991 Jan; 51(1):381-6. PubMed ID: 1846312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.
    Tong CY; Hui AB; Yin XL; Pang JC; Zhu XL; Poon WS; Ng HK
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):187-93. PubMed ID: 14758948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oncogene amplification in human neuroblastomas].
    Kanda N; Tsuchida Y; Hayashi Y; Ise T; Takayama J; Utakoji T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):661-6. PubMed ID: 3963837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S.
    Lavialle C; Modjtahedi N; Cassingena R; Brison O
    Oncogene; 1988 Sep; 3(3):335-9. PubMed ID: 3060796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplified and rearranged bcl-2 gene in two lymphoma cell lines, FL-218 and FL-318, carrying a 14;18 translocation.
    Amakawa R; Fukuhara S; Ohno H; Tanabe S; Horii M; Matsuyama F; Kato I; Kakita T; Nagauchi O
    Cancer Res; 1990 Apr; 50(8):2423-8. PubMed ID: 2180570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.
    Weidner U; Peter S; Strohmeyer T; Hussnätter R; Ackermann R; Sies H
    Cancer Res; 1990 Aug; 50(15):4504-9. PubMed ID: 1973362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system.
    Pietsch T; Scharmann T; Fonatsch C; Schmidt D; Ockler R; Freihoff D; Albrecht S; Wiestler OD; Zeltzer P; Riehm H
    Cancer Res; 1994 Jun; 54(12):3278-87. PubMed ID: 8205550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
    Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo.
    Bover L; Barrio M; Bravo AI; Slavutsky I; Larripa I; Bolondi A; Ayala M; Mordoh J
    Cell Mol Biol (Noisy-le-grand); 1998 May; 44(3):493-504. PubMed ID: 9620446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in growth properties of human papilloma virus type 16 immortalised human cervical keratinocyte cell line correlate with amplification and overexpression of c-myc oncogene.
    Crook T; Greenfield I; Howard J; Stanley M
    Oncogene; 1990 Apr; 5(4):619-22. PubMed ID: 2158040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification, expression and localization of the c-myc gene in BSp73 rat tumor cell lines.
    Birnbaum M; Spiess E
    Anticancer Res; 1988; 8(6):1185-91. PubMed ID: 2464334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenicity assay of the human mammary carcinoma cell line MCF-7.
    Marics I; Adelaide J; Rosnet O; Planche J; Pirisi V; Birnbaum D
    Anticancer Res; 1989; 9(6):1627-31. PubMed ID: 2560622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.
    Suchy BK; Sarafoff M; Kerler R; Rabes HM
    Cancer Res; 1989 Dec; 49(23):6781-7. PubMed ID: 2684400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.